JenaValve Raises $62.5 Million To Fund Transfemoral TAVI Trial And More
This article was originally published in The Gray Sheet
Funds will help the German company continue developing its JenaValve transcatheter aortic valve, including a new clinical trial of the transfemoral version of the system.
You may also be interested in...
Device and diagnostics companies both suffered declines in fundraising compared with previous quarters. The biggest medtech acquisition was Stryker’s $1.4 billion buyout of MAKO, while in diagnostics BioMeriux’s $450 million purchase of BioFire topped the list.
Medtech start-ups have closed on some impressive venture capital funding rounds so far this year, with the largest investments concentrated in a few “hot” technology areas. But the biotechnology industry garnered far more VC funding in Q2 than did the medical device sector, particularly with regards to early-stage funding.
CMS releases health care spending estimates. Boston Scientific opens new centers in Shanghai. New products from Crosstrees, Biotronik and JenaValve.